BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22706600)

  • 1. Inhibition of GTP cyclohydrolase reduces cancer pain in mice and enhances analgesic effects of morphine.
    Pickert G; Myrczek T; Rückert S; Weigert A; Häussler A; Ferreirós N; Brüne B; Lötsch J; Tegeder I
    J Mol Med (Berl); 2012 Dec; 90(12):1473-86. PubMed ID: 22706600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCH1 variants, tetrahydrobiopterin and their effects on pain sensitivity.
    Nasser A; Møller LB
    Scand J Pain; 2014 Apr; 5(2):121-128. PubMed ID: 29913682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired behavioural pain responses in hph-1 mice with inherited deficiency in GTP cyclohydrolase 1 in models of inflammatory pain.
    Nasser A; Bjerrum OJ; Heegaard AM; Møller AT; Larsen M; Dalbøge LS; Dupont E; Jensen TS; Møller LB
    Mol Pain; 2013 Feb; 9():5. PubMed ID: 23421753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of GTP cyclohydrolase attenuates tumor growth by reducing angiogenesis and M2-like polarization of tumor associated macrophages.
    Pickert G; Lim HY; Weigert A; Häussler A; Myrczek T; Waldner M; Labocha S; Ferreirós N; Geisslinger G; Lötsch J; Becker C; Brüne B; Tegeder I
    Int J Cancer; 2013 Feb; 132(3):591-604. PubMed ID: 22753274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell tetrahydrobiopterin contributes to itch in mice.
    Zschiebsch K; Fischer C; Wilken-Schmitz A; Geisslinger G; Channon K; Watschinger K; Tegeder I
    J Cell Mol Med; 2019 Feb; 23(2):985-1000. PubMed ID: 30450838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCH1, BH4 and pain.
    Latremoliere A; Costigan M
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1728-41. PubMed ID: 21466440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer.
    Cronin SJF; Rao S; Tejada MA; Turnes BL; Licht-Mayer S; Omura T; Brenneis C; Jacobs E; Barrett L; Latremoliere A; Andrews N; Channon KM; Latini A; Arvanites AC; Davidow LS; Costigan M; Rubin LL; Penninger JM; Woolf CJ
    Sci Transl Med; 2022 Aug; 14(660):eabj1531. PubMed ID: 36044597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.
    Tegeder I; Costigan M; Griffin RS; Abele A; Belfer I; Schmidt H; Ehnert C; Nejim J; Marian C; Scholz J; Wu T; Allchorne A; Diatchenko L; Binshtok AM; Goldman D; Adolph J; Sama S; Atlas SJ; Carlezon WA; Parsegian A; Lötsch J; Fillingim RB; Maixner W; Geisslinger G; Max MB; Woolf CJ
    Nat Med; 2006 Nov; 12(11):1269-77. PubMed ID: 17057711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype.
    Tegeder I; Adolph J; Schmidt H; Woolf CJ; Geisslinger G; Lötsch J
    Eur J Pain; 2008 Nov; 12(8):1069-77. PubMed ID: 18374612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model.
    Gao YJ; Cheng JK; Zeng Q; Xu ZZ; Decosterd I; Xu X; Ji RR
    Exp Neurol; 2009 Sep; 219(1):146-55. PubMed ID: 19445931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner.
    Wang Z; Zhang N; Zhang M; Jiang Y; Ng AS; Bridges E; Zhang W; Zeng X; Luo Q; Liang J; Győrffy B; Hublitz P; Liang Z; Fischer R; Kerr D; Harris AL; Cai S
    Cancer Res; 2023 Oct; 83(20):3400-3413. PubMed ID: 37463466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
    Huang Q; Sun ML; Chen Y; Li XY; Wang YX
    J Ethnopharmacol; 2017 Jan; 196():151-159. PubMed ID: 27989510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical and structural investigation of the regulation of human GTP cyclohydrolase I by its regulatory protein GFRP.
    Ebenhoch R; Bauer M; Reinert D; Kersting A; Huber S; Schmid A; Hinz I; Feiler M; Müller K; Nar H
    J Struct Biol; 2021 Mar; 213(1):107691. PubMed ID: 33387654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Human and Rodent Genetics to Identify New Analgesics.
    Latremoliere A; Costigan M
    Neurosci Bull; 2018 Feb; 34(1):143-155. PubMed ID: 28667479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.
    Cronin SJF; Seehus C; Weidinger A; Talbot S; Reissig S; Seifert M; Pierson Y; McNeill E; Longhi MS; Turnes BL; Kreslavsky T; Kogler M; Hoffmann D; Ticevic M; da Luz Scheffer D; Tortola L; Cikes D; Jais A; Rangachari M; Rao S; Paolino M; Novatchkova M; Aichinger M; Barrett L; Latremoliere A; Wirnsberger G; Lametschwandtner G; Busslinger M; Zicha S; Latini A; Robson SC; Waisman A; Andrews N; Costigan M; Channon KM; Weiss G; Kozlov AV; Tebbe M; Johnsson K; Woolf CJ; Penninger JM
    Nature; 2018 Nov; 563(7732):564-568. PubMed ID: 30405245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous mutations in GTP-cyclohydrolase-1 reduce BH4 biosynthesis but not pain sensitivity.
    Nasser A; Møller AT; Hellmund V; Thorborg SS; Jespersgaard C; Bjerrum OJ; Dupont E; Nachman G; Lykkesfeldt J; Jensen TS; Møller LB
    Pain; 2018 Jun; 159(6):1012-1024. PubMed ID: 29470312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of morphine and non-opioid analgesic adjuvants in a mouse model of skin cancer pain.
    Andoh T; Sugiyama K; Fujita M; Iida Y; Nojima H; Saiki I; Kuraishi Y
    Biol Pharm Bull; 2008 Mar; 31(3):520-2. PubMed ID: 18310922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk.
    Doehring A; Antoniades C; Channon KM; Tegeder I; Lötsch J
    Mutat Res; 2008; 659(3):195-201. PubMed ID: 18515178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer.
    Wei JL; Wu SY; Yang YS; Xiao Y; Jin X; Xu XE; Hu X; Li DQ; Jiang YZ; Shao ZM
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34281987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of GCH1promotes hepatocellular carcinoma growth by activating superoxide anion-mediated ASK1/p38 signaling via inhibiting tetrahydrobiopterin de novo biosynthesis.
    Zhong GC; Zhao ZB; Cheng Y; Wang YB; Qiu C; Mao LH; Hu JJ; Cai D; Liu Y; Gong JP; Li SW
    Free Radic Biol Med; 2021 May; 168():81-94. PubMed ID: 33781891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.